Medicine and Dentistry
Cardiomyocyte
100%
Heart
57%
Engineered Heart Tissue
46%
Stem Cell
45%
Tissues
40%
Muscle Contractility
39%
Cardiovascular System
38%
Pluripotent Stem Cell
38%
Drug Screening
36%
Pluripotent Stem Cell
35%
Stem Cell
35%
Differentiation
34%
Maturation
28%
Cells
28%
Disease
27%
Heart Tissue
23%
In Vitro
20%
Heart Function
20%
Chemotherapeutic Agent
18%
Drug
18%
Transcription Factor II
17%
Ovalbumin
17%
Myocardial Infarction
17%
Heart Performance
17%
Structure Analysis
17%
Alpha Actinin
17%
Assessment
17%
Retinoic Acid Receptor Alpha
17%
Analysis
17%
Positron Emission Tomography
17%
Cell Composition
17%
Adult
15%
Human Pluripotent Stem Cell
14%
Myofibril
13%
Learning
11%
Embryo Development
11%
Heart Disease
11%
Extracellular Matrix
10%
Stress
10%
Drug Safety
9%
Drug Response
9%
Culture
9%
Fibroblast
9%
Cell Culture
8%
Regenerative Medicine
8%
High Throughput Screening
8%
Phenotype
7%
Cardiotoxicity
7%
Smooth Muscle Cell
7%
Tissue Engineering
7%
Biochemistry, Genetics and Molecular Biology
Force
35%
Muscle Contractility
35%
Embryonic Stem Cell
35%
Cellular Differentiation
35%
Mesoderm
23%
Time
23%
Stress
19%
Volume
19%
Ovalbumin
17%
Transcription Factor II
17%
Chick
17%
Rigidity
17%
Actinin
17%
Light
17%
Retinoic Acid Receptor Alpha
17%
Kinetics
17%
Velocity
17%
Atrial Fibrillation
17%
P-Glycoprotein
17%
Drug Screening
14%
Perfusion
13%
Myofibril
13%
Disease Modeling
13%
Tretinoin
13%
Stem Cell Line
10%
Cell Proliferation
10%
Cell Culture
10%
Stem Cell
9%
McHerry
8%
Morphogen
8%
Agonist
8%
Experiment
8%
Drug Response
8%
Surface Area
8%
Videorecording
8%
Fibroblast
8%
Genetic Mechanism
8%
Cell Immortalization
7%
CRISPR/Cas9
5%
Fluorescence
5%
Heart Rhythm
5%
Genetics
5%
Computer Model
5%
Life
5%
Aging
5%
Animal Models
5%
High Throughput Screening
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Screening
61%
Diseases
58%
Cardiotoxicity
57%
Drug
28%
ABC Transporter
17%
Transcription Factor
17%
P-Glycoprotein
17%
Heart Arrhythmia
17%
Fluorescence Microscopy
17%
Cardiac Agent
17%
Disease Model
17%
Atrial Fibrillation
17%
High-Throughput Screening
17%
Doxorubicin
12%
Animal
11%
Heart Failure
11%
Drug Discovery
8%
Diseases
8%
Amrubicin
7%
Aclarubicin
7%
Heart Disease
6%
Anticarcinogen
5%
Injury
5%
Deterioration
5%
Safety Pharmacology
5%